# Invesco Biotechnology & Genome ETF (PBE)

> Source: Nexqual · https://nexqual.com/PBE · data as of 2026-10-23 19:54 UTC · cite as "Nexqual, Invesco Biotechnology & Genome ETF (PBE), nexqual.com/PBE" · informational, not investment advice.

**Price:** USD 98.72 (-0.67% on the day) · last close of Oct 23, 2026; US market closed, not a live price. Prev close 99.38 · day 97.57–98.72 · 52w 72.27–99.99 · market cap null · PCX

## Key facts
- Total return with dividends: 1Y +36.6% vs S&P 500 +13.4%; 5Y +34.5% vs S&P 500 +76.9%.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-24) | 5Y (from 2021-10-25) |
|---|---|---|
| Total return | +36.6% | +34.5% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | +36.8% | +6.1% |
| Volatility (annualized) | 19.8% | 21.6% |
| Max drawdown | -11.7% (Jan 2026→Mar 2026) | -30.0% (Oct 2021→Oct 2023) |

## Peers
PJP (Invesco Pharmaceuticals ETF) USD 125.03 -1.79% · FBT (First Trust Amex Biotech Index ) USD 269.25 -1.26% · PBJ (Invesco Food & Beverage ETF) USD 47.93 -1.03% · PKB (Invesco Building & Construction) USD 85.44 -1.33% · BBH (VanEck Biotech ETF) USD 246.57 -0.74%

## More
Full page: https://nexqual.com/PBE · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Options: expected move (Cboe, 15-min delayed)

| Expiration | Days | ATM IV | Expected move |
|---|---|---|---|
| 2026-11-20 | 27 | 28.4% | ±6.3% |
| 2026-12-18 | 55 | 26.7% | ±8.5% |
| 2027-03-19 | 146 | 21.5% | ±10.8% |
| 2027-06-17 | 236 | 21.6% | ±13.9% |